BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3327363)

  • 1. Interaction of noradrenaline, NPY and VIP with the neurogenic cholinergic response of the rat uterine cervix in vitro.
    Stjernquist M; Owman C
    Acta Physiol Scand; 1987 Dec; 131(4):553-62. PubMed ID: 3327363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic and adrenergic neural control of smooth muscle function in the non-pregnant rat uterine cervix.
    Stjernquist M; Owman C
    Acta Physiol Scand; 1985 Jul; 124(3):429-36. PubMed ID: 4050475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of neuropeptide Y on electrically induced contractions in the longitudinal and circular smooth muscle layers of the female rabbit urethra.
    Sjögren C; Andersson KE; Andersson PO; Mattiasson A; Uvelius B
    Acta Physiol Scand; 1988 Jun; 133(2):177-81. PubMed ID: 2852440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal polypeptide (VIP) inhibits neurally evoked smooth muscle activity of rat uterine cervix in vitro.
    Stjernquist M; Owman C
    Regul Pept; 1984 Mar; 8(2):161-7. PubMed ID: 6328586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of porcine lacrimal gland secretion by non-cholinergic, non-adrenergic nerves: effects of electrical field stimulation, VIP and NPY.
    Adeghate EA; Singh J; Howarth FC; Burrows S
    Brain Res; 1997 May; 758(1-2):127-35. PubMed ID: 9203541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
    Pernow J; Saria A; Lundberg JM
    Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evidence for a prejunctional action of neuropeptide Y on cholinergic motor neurons in the rat uterine cervix.
    Stjernquist M; Owman C
    Acta Physiol Scand; 1990 Jan; 138(1):95-6. PubMed ID: 2309574
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
    Oellerich WF; Malik KU
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and functional characterization of a rat vaginal smooth muscle sphincter.
    Giraldi A; Alm P; Werkström V; Myllymäki L; Wagner G; Andersson KE
    Int J Impot Res; 2002 Aug; 14(4):271-82. PubMed ID: 12152117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smooth muscle pharmacology in the isolated virgin and pregnant rat uterus and cervix.
    Darios ES; Seitz B; Watts SW
    J Pharmacol Exp Ther; 2012 Jun; 341(3):587-96. PubMed ID: 22366660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasoactive intestinal peptide (VIP) on the mechanical activity and [3H] acetylcholine release in guinea-pig gastric muscle.
    Milenov K; Kalfin R; Mandrek K
    Acta Physiol Pharmacol Bulg; 1991; 17(2-3):13-8. PubMed ID: 1819910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of the inhibitory action of neuropeptide Y (NPY) in guinea-pig trachea by the C-terminal fragment NPY (2-36).
    Taoudi Benchekroun M; St-Pierre S; Fournier A; Cadieux A
    Br J Pharmacol; 1993 Aug; 109(4):902-4. PubMed ID: 8401942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F; Argiolas L; Ruvolo G; del Basso P
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of D-myo inositol 1,2,6 trisphosphate to inhibit contractile activity in rat ventricular cardiomyocytes induced by neuropeptide Y and other cardioactive peptides through phospholipase C.
    Bell D; Millar BC; McDermott BJ
    Br J Pharmacol; 1997 Dec; 122(8):1655-60. PubMed ID: 9422811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
    Ottesen B
    Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High spatial resolution studies of muscarinic neuroeffector junctions in mouse isolated vas deferens.
    Cuprian-Beltechi AM; Solanki P; Teramoto N; Cunnane TC
    Neuroscience; 2009 Sep; 162(4):1366-76. PubMed ID: 19486927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.